ImmuCell Corporation Proceeds from Issuance of Debt
ImmuCell Corporation (ICCC) reported Proceeds from Issuance of Debt of $2.33 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2025-11-13
- ImmuCell Corporation proceeds from issuance of debt for the quarter ending 2025-09-30 was $2.33M.
- ImmuCell Corporation proceeds from issuance of debt for the quarter ending 2024-12-31 was $0.00.
- ImmuCell Corporation proceeds from issuance of debt for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation proceeds from issuance of debt for the quarter ending 2023-12-31 was $0.00.
- ImmuCell Corporation proceeds from issuance of debt for fiscal 2021 was $400.00K, a 96.53% decline from fiscal 2020.
- ImmuCell Corporation proceeds from issuance of debt for fiscal 2020 was $11.54M.
- ImmuCell Corporation proceeds from issuance of debt for fiscal 2018 was $693.64K, a 88.71% decline from fiscal 2017.
- ImmuCell Corporation proceeds from issuance of debt for fiscal 2017 was $6.15M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.33M 10-Q · filed 2025-11-13 | $2.33M 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $3.00M derived: sum of 2 quarters · filed 2025-11-13 | $3.00M 10-Q · filed 2025-11-13 | |
| 2023-09-30 | $3.00M 10-Q · filed 2024-11-13 | $3.00M 10-Q · filed 2024-11-13 | ||
| 2022-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $2.00M 10-Q · filed 2024-11-13 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $2.00M 10-Q · filed 2023-11-13 | $2.00M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.00M 10-Q · filed 2023-08-10 | $2.00M derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-11 | $2.00M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $400.00K 10-K · filed 2023-03-29 | ||
| 2021-09-30 | $400.00K 10-Q · filed 2022-11-21 | |||
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.50M derived: sum of 2 quarters · filed 2022-03-30 | $2.94M derived: sum of 3 quarters · filed 2022-03-30 | $11.54M 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.44M derived: sum of 2 quarters · filed 2021-11-15 | $10.04M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.44M 10-Q · filed 2020-08-12 | $10.04M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $8.60M 10-Q · filed 2021-05-13 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $426.50K derived: sum of 2 quarters · filed 2020-03-27 | $426.50K derived: sum of 3 quarters · filed 2020-03-27 | $693.64K 10-K · filed 2020-03-27 |
| 2018-09-30 | $426.50K 10-Q · filed 2019-11-12 | $426.50K derived: sum of 2 quarters · filed 2019-11-12 | $693.64K 10-Q · filed 2019-11-12 | $3.82M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $267.14K 10-Q · filed 2019-08-12 | $3.39M derived: sum of 3 quarters · filed 2019-08-12 | $5.57M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $267.14K 10-Q · filed 2019-05-13 | $3.39M derived: sum of 2 quarters · filed 2019-05-13 | $5.57M derived: sum of 3 quarters · filed 2019-05-13 | $6.07M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $5.31M derived: sum of 2 quarters · filed 2019-03-22 | $5.81M derived: sum of 3 quarters · filed 2019-03-22 | $6.15M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.18M 10-Q · filed 2018-11-13 | $2.68M derived: sum of 2 quarters · filed 2018-11-13 | $3.02M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $500.00K 10-Q · filed 2018-08-13 | $840.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $340.00K 10-Q · filed 2018-05-14 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $2.50M 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $2.50M 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 10-K · filed 2016-03-25 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-25 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $0.00 10-K · filed 2014-03-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $0.00 10-Q/A · filed 2012-09-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $0.00 derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $0.00 derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $600.00K 10-K · filed 2014-03-26 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $600.00K 10-Q · filed 2012-11-13 | $600.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $600.00K 10-Q/A · filed 2012-09-07 | $600.00K derived: sum of 3 quarters · filed 2013-03-28 | $1.60M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $600.00K 10-Q · filed 2012-05-14 | $600.00K derived: sum of 2 quarters · filed 2013-03-28 | $1.60M derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.00M derived: sum of 2 quarters · filed 2013-03-28 | $1.00M 10-K · filed 2013-03-28 | |
| 2010-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.00M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |